Global Hospital-Acquired Infections Assays Market Research Report 2026(Status and Outlook)
Hospital-acquired infections assays refer to diagnostic tests and assays designed to identify and detect infections that patients may acquire during their stay in healthcare facilities, such as hospitals. These assays play a crucial role in early and accurate diagnosis, enabling healthcare providers to implement timely interventions and prevent the spread of infections within healthcare settings.
The global Hospital-Acquired Infections Assays market size was estimated at USD 4680.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hospital-Acquired Infections Assays market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hospital-Acquired Infections Assays market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hospital-Acquired Infections Assays market.
Global Hospital-Acquired Infections Assays Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BIOM?RIEUX
Abbott
F. Hoffmann-La Roche Ltd.
Siemens Healthcare Private Limited
BD (Becton, Dickinson and Company)
Bioscience, Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Meridian Bioscience, Inc.
Hologic, Inc.
Market Segmentation (by Type)
Blood Tests
Urinalysis
Market Segmentation (by Application)
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hospital-Acquired Infections Assays Market
Overview of the regional outlook of the Hospital-Acquired Infections Assays Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-Acquired Infections Assays Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hospital-Acquired Infections Assays, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Hospital-Acquired Infections Assays market size was estimated at USD 4680.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 7.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hospital-Acquired Infections Assays market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hospital-Acquired Infections Assays market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hospital-Acquired Infections Assays market.
Global Hospital-Acquired Infections Assays Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BIOM?RIEUX
Abbott
F. Hoffmann-La Roche Ltd.
Siemens Healthcare Private Limited
BD (Becton, Dickinson and Company)
Bioscience, Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Meridian Bioscience, Inc.
Hologic, Inc.
Market Segmentation (by Type)
Blood Tests
Urinalysis
Market Segmentation (by Application)
Urinary Tract Infections
Pneumonia
Surgical Site Infections
Bloodstream Infections
Other Hospital Infections
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hospital-Acquired Infections Assays Market
Overview of the regional outlook of the Hospital-Acquired Infections Assays Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hospital-Acquired Infections Assays Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hospital-Acquired Infections Assays, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hospital-Acquired Infections Assays
1.2 Key Market Segments
1.2.1 Hospital-Acquired Infections Assays Segment by Type
1.2.2 Hospital-Acquired Infections Assays Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hospital-Acquired Infections Assays Product Life Cycle
3.3 Global Hospital-Acquired Infections Assays Revenue Market Share by Company (2020-2025)
3.4 Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Hospital-Acquired Infections Assays Market Competitive Situation and Trends
3.6.1 Hospital-Acquired Infections Assays Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hospital-Acquired Infections Assays Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTIONS ASSAYS VALUE CHAIN ANALYSIS
4.1 Hospital-Acquired Infections Assays Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hospital-Acquired Infections Assays Market Porter's Five Forces Analysis
6 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-Acquired Infections Assays Market by Type (2020-2025)
6.3 Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type (2021-2025)
7 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-Acquired Infections Assays Market Size (M USD) by Application (2020-2025)
7.3 Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application (2021-2025)
8 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET SEGMENTATION BY REGION
8.1 Global Hospital-Acquired Infections Assays Market Size by Region
8.1.1 Global Hospital-Acquired Infections Assays Market Size by Region
8.1.2 Global Hospital-Acquired Infections Assays Market Size Market Share by Region
8.2 North America
8.2.1 North America Hospital-Acquired Infections Assays Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hospital-Acquired Infections Assays Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Hospital-Acquired Infections Assays Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hospital-Acquired Infections Assays Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hospital-Acquired Infections Assays Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 BIOM?RIEUX
9.1.1 BIOM?RIEUX Basic Information
9.1.2 BIOM?RIEUX Hospital-Acquired Infections Assays Product Overview
9.1.3 BIOM?RIEUX Hospital-Acquired Infections Assays Product Market Performance
9.1.4 BIOM?RIEUX SWOT Analysis
9.1.5 BIOM?RIEUX Business Overview
9.1.6 BIOM?RIEUX Recent Developments
9.2 Abbott
9.2.1 Abbott Basic Information
9.2.2 Abbott Hospital-Acquired Infections Assays Product Overview
9.2.3 Abbott Hospital-Acquired Infections Assays Product Market Performance
9.2.4 Abbott SWOT Analysis
9.2.5 Abbott Business Overview
9.2.6 Abbott Recent Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 F. Hoffmann-La Roche Ltd. Basic Information
9.3.2 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Overview
9.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd. SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd. Business Overview
9.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.4 Siemens Healthcare Private Limited
9.4.1 Siemens Healthcare Private Limited Basic Information
9.4.2 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Overview
9.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Market Performance
9.4.4 Siemens Healthcare Private Limited Business Overview
9.4.5 Siemens Healthcare Private Limited Recent Developments
9.5 BD (Becton, Dickinson and Company)
9.5.1 BD (Becton, Dickinson and Company) Basic Information
9.5.2 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Overview
9.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Market Performance
9.5.4 BD (Becton, Dickinson and Company) Business Overview
9.5.5 BD (Becton, Dickinson and Company) Recent Developments
9.6 Bioscience, Inc.
9.6.1 Bioscience, Inc. Basic Information
9.6.2 Bioscience, Inc. Hospital-Acquired Infections Assays Product Overview
9.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Product Market Performance
9.6.4 Bioscience, Inc. Business Overview
9.6.5 Bioscience, Inc. Recent Developments
9.7 QIAGEN
9.7.1 QIAGEN Basic Information
9.7.2 QIAGEN Hospital-Acquired Infections Assays Product Overview
9.7.3 QIAGEN Hospital-Acquired Infections Assays Product Market Performance
9.7.4 QIAGEN Business Overview
9.7.5 QIAGEN Recent Developments
9.8 Thermo Fisher Scientific Inc.
9.8.1 Thermo Fisher Scientific Inc. Basic Information
9.8.2 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Overview
9.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Market Performance
9.8.4 Thermo Fisher Scientific Inc. Business Overview
9.8.5 Thermo Fisher Scientific Inc. Recent Developments
9.9 Meridian Bioscience, Inc.
9.9.1 Meridian Bioscience, Inc. Basic Information
9.9.2 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Overview
9.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Market Performance
9.9.4 Meridian Bioscience, Inc. Business Overview
9.9.5 Meridian Bioscience, Inc. Recent Developments
9.10 Hologic, Inc.
9.10.1 Hologic, Inc. Basic Information
9.10.2 Hologic, Inc. Hospital-Acquired Infections Assays Product Overview
9.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Product Market Performance
9.10.4 Hologic, Inc. Business Overview
9.10.5 Hologic, Inc. Recent Developments
10 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET FORECAST BY REGION
10.1 Global Hospital-Acquired Infections Assays Market Size Forecast
10.2 Global Hospital-Acquired Infections Assays Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hospital-Acquired Infections Assays Market Size Forecast by Country
10.2.3 Asia Pacific Hospital-Acquired Infections Assays Market Size Forecast by Region
10.2.4 South America Hospital-Acquired Infections Assays Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Hospital-Acquired Infections Assays by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Hospital-Acquired Infections Assays Market Forecast by Type (2026-2035)
11.1.1 Global Hospital-Acquired Infections Assays Market Size Forecast by Type (2026-2035)
11.2 Global Hospital-Acquired Infections Assays Market Forecast by Application (2026-2035)
11.2.1 Global Hospital-Acquired Infections Assays Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hospital-Acquired Infections Assays
1.2 Key Market Segments
1.2.1 Hospital-Acquired Infections Assays Segment by Type
1.2.2 Hospital-Acquired Infections Assays Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hospital-Acquired Infections Assays Product Life Cycle
3.3 Global Hospital-Acquired Infections Assays Revenue Market Share by Company (2020-2025)
3.4 Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Hospital-Acquired Infections Assays Market Competitive Situation and Trends
3.6.1 Hospital-Acquired Infections Assays Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hospital-Acquired Infections Assays Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTIONS ASSAYS VALUE CHAIN ANALYSIS
4.1 Hospital-Acquired Infections Assays Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hospital-Acquired Infections Assays Market Porter's Five Forces Analysis
6 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hospital-Acquired Infections Assays Market by Type (2020-2025)
6.3 Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type (2021-2025)
7 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hospital-Acquired Infections Assays Market Size (M USD) by Application (2020-2025)
7.3 Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application (2021-2025)
8 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET SEGMENTATION BY REGION
8.1 Global Hospital-Acquired Infections Assays Market Size by Region
8.1.1 Global Hospital-Acquired Infections Assays Market Size by Region
8.1.2 Global Hospital-Acquired Infections Assays Market Size Market Share by Region
8.2 North America
8.2.1 North America Hospital-Acquired Infections Assays Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hospital-Acquired Infections Assays Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Hospital-Acquired Infections Assays Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hospital-Acquired Infections Assays Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hospital-Acquired Infections Assays Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 BIOM?RIEUX
9.1.1 BIOM?RIEUX Basic Information
9.1.2 BIOM?RIEUX Hospital-Acquired Infections Assays Product Overview
9.1.3 BIOM?RIEUX Hospital-Acquired Infections Assays Product Market Performance
9.1.4 BIOM?RIEUX SWOT Analysis
9.1.5 BIOM?RIEUX Business Overview
9.1.6 BIOM?RIEUX Recent Developments
9.2 Abbott
9.2.1 Abbott Basic Information
9.2.2 Abbott Hospital-Acquired Infections Assays Product Overview
9.2.3 Abbott Hospital-Acquired Infections Assays Product Market Performance
9.2.4 Abbott SWOT Analysis
9.2.5 Abbott Business Overview
9.2.6 Abbott Recent Developments
9.3 F. Hoffmann-La Roche Ltd.
9.3.1 F. Hoffmann-La Roche Ltd. Basic Information
9.3.2 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Overview
9.3.3 F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Market Performance
9.3.4 F. Hoffmann-La Roche Ltd. SWOT Analysis
9.3.5 F. Hoffmann-La Roche Ltd. Business Overview
9.3.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.4 Siemens Healthcare Private Limited
9.4.1 Siemens Healthcare Private Limited Basic Information
9.4.2 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Overview
9.4.3 Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Market Performance
9.4.4 Siemens Healthcare Private Limited Business Overview
9.4.5 Siemens Healthcare Private Limited Recent Developments
9.5 BD (Becton, Dickinson and Company)
9.5.1 BD (Becton, Dickinson and Company) Basic Information
9.5.2 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Overview
9.5.3 BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Market Performance
9.5.4 BD (Becton, Dickinson and Company) Business Overview
9.5.5 BD (Becton, Dickinson and Company) Recent Developments
9.6 Bioscience, Inc.
9.6.1 Bioscience, Inc. Basic Information
9.6.2 Bioscience, Inc. Hospital-Acquired Infections Assays Product Overview
9.6.3 Bioscience, Inc. Hospital-Acquired Infections Assays Product Market Performance
9.6.4 Bioscience, Inc. Business Overview
9.6.5 Bioscience, Inc. Recent Developments
9.7 QIAGEN
9.7.1 QIAGEN Basic Information
9.7.2 QIAGEN Hospital-Acquired Infections Assays Product Overview
9.7.3 QIAGEN Hospital-Acquired Infections Assays Product Market Performance
9.7.4 QIAGEN Business Overview
9.7.5 QIAGEN Recent Developments
9.8 Thermo Fisher Scientific Inc.
9.8.1 Thermo Fisher Scientific Inc. Basic Information
9.8.2 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Overview
9.8.3 Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Market Performance
9.8.4 Thermo Fisher Scientific Inc. Business Overview
9.8.5 Thermo Fisher Scientific Inc. Recent Developments
9.9 Meridian Bioscience, Inc.
9.9.1 Meridian Bioscience, Inc. Basic Information
9.9.2 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Overview
9.9.3 Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Market Performance
9.9.4 Meridian Bioscience, Inc. Business Overview
9.9.5 Meridian Bioscience, Inc. Recent Developments
9.10 Hologic, Inc.
9.10.1 Hologic, Inc. Basic Information
9.10.2 Hologic, Inc. Hospital-Acquired Infections Assays Product Overview
9.10.3 Hologic, Inc. Hospital-Acquired Infections Assays Product Market Performance
9.10.4 Hologic, Inc. Business Overview
9.10.5 Hologic, Inc. Recent Developments
10 HOSPITAL-ACQUIRED INFECTIONS ASSAYS MARKET FORECAST BY REGION
10.1 Global Hospital-Acquired Infections Assays Market Size Forecast
10.2 Global Hospital-Acquired Infections Assays Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hospital-Acquired Infections Assays Market Size Forecast by Country
10.2.3 Asia Pacific Hospital-Acquired Infections Assays Market Size Forecast by Region
10.2.4 South America Hospital-Acquired Infections Assays Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Hospital-Acquired Infections Assays by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Hospital-Acquired Infections Assays Market Forecast by Type (2026-2035)
11.1.1 Global Hospital-Acquired Infections Assays Market Size Forecast by Type (2026-2035)
11.2 Global Hospital-Acquired Infections Assays Market Forecast by Application (2026-2035)
11.2.1 Global Hospital-Acquired Infections Assays Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hospital-Acquired Infections Assays Market Size by Type (M USD)
Table 4. Global Hospital-Acquired Infections Assays Market Size by Application
Table 5. Hospital-Acquired Infections Assays Market Size Comparison by Region (M USD)
Table 6. Global Hospital-Acquired Infections Assays Revenue (M USD) by Company (2020-2025)
Table 7. Global Hospital-Acquired Infections Assays Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infections Assays as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Hospital-Acquired Infections Assays Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Hospital-Acquired Infections Assays Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Hospital-Acquired Infections Assays Market Size by Type (M USD)
Table 22. Global Hospital-Acquired Infections Assays Market Size (M USD) by Type (2020-2025)
Table 23. Global Hospital-Acquired Infections Assays Market Share by Type (2020-2025)
Table 24. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type (2021-2025)
Table 25. Global Hospital-Acquired Infections Assays Market Size by Application
Table 26. Global Hospital-Acquired Infections Assays Market Size by Application (2020-2025) & (M USD)
Table 27. Global Hospital-Acquired Infections Assays Market Share by Application (2020-2025)
Table 28. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application (2021-2025)
Table 29. Global Hospital-Acquired Infections Assays Market Size by Region (2020-2025) & (M USD)
Table 30. Global Hospital-Acquired Infections Assays Market Size Market Share by Region (2020-2025)
Table 31. North America Hospital-Acquired Infections Assays Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Hospital-Acquired Infections Assays Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Hospital-Acquired Infections Assays Market Size by Region (2020-2025) & (M USD)
Table 34. South America Hospital-Acquired Infections Assays Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Hospital-Acquired Infections Assays Market Size by Region (2020-2025) & (M USD)
Table 36. BIOM?RIEUX Basic Information
Table 37. BIOM?RIEUX Hospital-Acquired Infections Assays Product Overview
Table 38. BIOM?RIEUX Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 39. BIOM?RIEUX SWOT Analysis
Table 40. BIOM?RIEUX Business Overview
Table 41. BIOM?RIEUX Recent Developments
Table 42. Abbott Basic Information
Table 43. Abbott Hospital-Acquired Infections Assays Product Overview
Table 44. Abbott Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Abbott SWOT Analysis
Table 46. Abbott Business Overview
Table 47. Abbott Recent Developments
Table 48. F. Hoffmann-La Roche Ltd. Basic Information
Table 49. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Overview
Table 50. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 51. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 52. F. Hoffmann-La Roche Ltd. Business Overview
Table 53. F. Hoffmann-La Roche Ltd. Recent Developments
Table 54. Siemens Healthcare Private Limited Basic Information
Table 55. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Overview
Table 56. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Siemens Healthcare Private Limited Business Overview
Table 58. Siemens Healthcare Private Limited Recent Developments
Table 59. BD (Becton, Dickinson and Company) Basic Information
Table 60. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Overview
Table 61. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 62. BD (Becton, Dickinson and Company) Business Overview
Table 63. BD (Becton, Dickinson and Company) Recent Developments
Table 64. Bioscience, Inc. Basic Information
Table 65. Bioscience, Inc. Hospital-Acquired Infections Assays Product Overview
Table 66. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Bioscience, Inc. Business Overview
Table 68. Bioscience, Inc. Recent Developments
Table 69. QIAGEN Basic Information
Table 70. QIAGEN Hospital-Acquired Infections Assays Product Overview
Table 71. QIAGEN Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 72. QIAGEN Business Overview
Table 73. QIAGEN Recent Developments
Table 74. Thermo Fisher Scientific Inc. Basic Information
Table 75. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Overview
Table 76. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Thermo Fisher Scientific Inc. Business Overview
Table 78. Thermo Fisher Scientific Inc. Recent Developments
Table 79. Meridian Bioscience, Inc. Basic Information
Table 80. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Overview
Table 81. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Meridian Bioscience, Inc. Business Overview
Table 83. Meridian Bioscience, Inc. Recent Developments
Table 84. Hologic, Inc. Basic Information
Table 85. Hologic, Inc. Hospital-Acquired Infections Assays Product Overview
Table 86. Hologic, Inc. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Hologic, Inc. Business Overview
Table 88. Hologic, Inc. Recent Developments
Table 89. Global Hospital-Acquired Infections Assays Market Size Forecast by Region (2026-2035) & (M USD)
Table 90. North America Hospital-Acquired Infections Assays Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Europe Hospital-Acquired Infections Assays Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Asia Pacific Hospital-Acquired Infections Assays Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Hospital-Acquired Infections Assays Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Middle East and Africa Hospital-Acquired Infections Assays Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Global Hospital-Acquired Infections Assays Market Size Forecast by Type (2026-2035) & (M USD)
Table 96. Global Hospital-Acquired Infections Assays Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hospital-Acquired Infections Assays Market Size by Type (M USD)
Table 4. Global Hospital-Acquired Infections Assays Market Size by Application
Table 5. Hospital-Acquired Infections Assays Market Size Comparison by Region (M USD)
Table 6. Global Hospital-Acquired Infections Assays Revenue (M USD) by Company (2020-2025)
Table 7. Global Hospital-Acquired Infections Assays Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infections Assays as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Hospital-Acquired Infections Assays Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Hospital-Acquired Infections Assays Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Hospital-Acquired Infections Assays Market Size by Type (M USD)
Table 22. Global Hospital-Acquired Infections Assays Market Size (M USD) by Type (2020-2025)
Table 23. Global Hospital-Acquired Infections Assays Market Share by Type (2020-2025)
Table 24. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type (2021-2025)
Table 25. Global Hospital-Acquired Infections Assays Market Size by Application
Table 26. Global Hospital-Acquired Infections Assays Market Size by Application (2020-2025) & (M USD)
Table 27. Global Hospital-Acquired Infections Assays Market Share by Application (2020-2025)
Table 28. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application (2021-2025)
Table 29. Global Hospital-Acquired Infections Assays Market Size by Region (2020-2025) & (M USD)
Table 30. Global Hospital-Acquired Infections Assays Market Size Market Share by Region (2020-2025)
Table 31. North America Hospital-Acquired Infections Assays Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Hospital-Acquired Infections Assays Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Hospital-Acquired Infections Assays Market Size by Region (2020-2025) & (M USD)
Table 34. South America Hospital-Acquired Infections Assays Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Hospital-Acquired Infections Assays Market Size by Region (2020-2025) & (M USD)
Table 36. BIOM?RIEUX Basic Information
Table 37. BIOM?RIEUX Hospital-Acquired Infections Assays Product Overview
Table 38. BIOM?RIEUX Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 39. BIOM?RIEUX SWOT Analysis
Table 40. BIOM?RIEUX Business Overview
Table 41. BIOM?RIEUX Recent Developments
Table 42. Abbott Basic Information
Table 43. Abbott Hospital-Acquired Infections Assays Product Overview
Table 44. Abbott Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 45. Abbott SWOT Analysis
Table 46. Abbott Business Overview
Table 47. Abbott Recent Developments
Table 48. F. Hoffmann-La Roche Ltd. Basic Information
Table 49. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Product Overview
Table 50. F. Hoffmann-La Roche Ltd. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 51. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 52. F. Hoffmann-La Roche Ltd. Business Overview
Table 53. F. Hoffmann-La Roche Ltd. Recent Developments
Table 54. Siemens Healthcare Private Limited Basic Information
Table 55. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Product Overview
Table 56. Siemens Healthcare Private Limited Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Siemens Healthcare Private Limited Business Overview
Table 58. Siemens Healthcare Private Limited Recent Developments
Table 59. BD (Becton, Dickinson and Company) Basic Information
Table 60. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Product Overview
Table 61. BD (Becton, Dickinson and Company) Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 62. BD (Becton, Dickinson and Company) Business Overview
Table 63. BD (Becton, Dickinson and Company) Recent Developments
Table 64. Bioscience, Inc. Basic Information
Table 65. Bioscience, Inc. Hospital-Acquired Infections Assays Product Overview
Table 66. Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Bioscience, Inc. Business Overview
Table 68. Bioscience, Inc. Recent Developments
Table 69. QIAGEN Basic Information
Table 70. QIAGEN Hospital-Acquired Infections Assays Product Overview
Table 71. QIAGEN Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 72. QIAGEN Business Overview
Table 73. QIAGEN Recent Developments
Table 74. Thermo Fisher Scientific Inc. Basic Information
Table 75. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Product Overview
Table 76. Thermo Fisher Scientific Inc. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Thermo Fisher Scientific Inc. Business Overview
Table 78. Thermo Fisher Scientific Inc. Recent Developments
Table 79. Meridian Bioscience, Inc. Basic Information
Table 80. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Product Overview
Table 81. Meridian Bioscience, Inc. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Meridian Bioscience, Inc. Business Overview
Table 83. Meridian Bioscience, Inc. Recent Developments
Table 84. Hologic, Inc. Basic Information
Table 85. Hologic, Inc. Hospital-Acquired Infections Assays Product Overview
Table 86. Hologic, Inc. Hospital-Acquired Infections Assays Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Hologic, Inc. Business Overview
Table 88. Hologic, Inc. Recent Developments
Table 89. Global Hospital-Acquired Infections Assays Market Size Forecast by Region (2026-2035) & (M USD)
Table 90. North America Hospital-Acquired Infections Assays Market Size Forecast by Country (2026-2035) & (M USD)
Table 91. Europe Hospital-Acquired Infections Assays Market Size Forecast by Country (2026-2035) & (M USD)
Table 92. Asia Pacific Hospital-Acquired Infections Assays Market Size Forecast by Region (2026-2035) & (M USD)
Table 93. South America Hospital-Acquired Infections Assays Market Size Forecast by Country (2026-2035) & (M USD)
Table 94. Middle East and Africa Hospital-Acquired Infections Assays Market Size Forecast by Country (2026-2035) & (M USD)
Table 95. Global Hospital-Acquired Infections Assays Market Size Forecast by Type (2026-2035) & (M USD)
Table 96. Global Hospital-Acquired Infections Assays Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Hospital-Acquired Infections Assays
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-Acquired Infections Assays Market Size (M USD), 2025-2035
Figure 5. Global Hospital-Acquired Infections Assays Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Hospital-Acquired Infections Assays Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Hospital-Acquired Infections Assays Product Life Cycle
Figure 12. Global Hospital-Acquired Infections Assays Revenue Share by Company in 2025
Figure 13. Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Hospital-Acquired Infections Assays Revenue in 2025
Figure 15. Value Chain Map of Hospital-Acquired Infections Assays
Figure 16. Global Hospital-Acquired Infections Assays Market PEST Analysis
Figure 17. Global Hospital-Acquired Infections Assays Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Hospital-Acquired Infections Assays Market Share by Type
Figure 20. Market Share of Hospital-Acquired Infections Assays by Type (2020-2025)
Figure 21. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hospital-Acquired Infections Assays Market Share by Application
Figure 24. Global Hospital-Acquired Infections Assays Market Share by Application (2020-2025)
Figure 25. Global Hospital-Acquired Infections Assays Market Share by Application in 2024
Figure 26. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Hospital-Acquired Infections Assays Market Size Market Share by Region (2020-2025)
Figure 28. North America Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Hospital-Acquired Infections Assays Market Size Market Share by Country in 2024
Figure 30. U.S. Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Hospital-Acquired Infections Assays Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Hospital-Acquired Infections Assays Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Hospital-Acquired Infections Assays Market Share by Country in 2024
Figure 35. Germany Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Hospital-Acquired Infections Assays Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Hospital-Acquired Infections Assays Market Size Market Share by Region in 2024
Figure 42. China Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Hospital-Acquired Infections Assays Market Size and Growth Rate (M USD)
Figure 48. South America Hospital-Acquired Infections Assays Market Size Market Share by Country in 2024
Figure 49. Brazil Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Hospital-Acquired Infections Assays Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Hospital-Acquired Infections Assays Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Hospital-Acquired Infections Assays Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Hospital-Acquired Infections Assays Market Share Forecast by Type (2026-2035)
Figure 61. Global Hospital-Acquired Infections Assays Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Hospital-Acquired Infections Assays
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hospital-Acquired Infections Assays Market Size (M USD), 2025-2035
Figure 5. Global Hospital-Acquired Infections Assays Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Hospital-Acquired Infections Assays Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Hospital-Acquired Infections Assays Product Life Cycle
Figure 12. Global Hospital-Acquired Infections Assays Revenue Share by Company in 2025
Figure 13. Hospital-Acquired Infections Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Hospital-Acquired Infections Assays Revenue in 2025
Figure 15. Value Chain Map of Hospital-Acquired Infections Assays
Figure 16. Global Hospital-Acquired Infections Assays Market PEST Analysis
Figure 17. Global Hospital-Acquired Infections Assays Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Hospital-Acquired Infections Assays Market Share by Type
Figure 20. Market Share of Hospital-Acquired Infections Assays by Type (2020-2025)
Figure 21. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hospital-Acquired Infections Assays Market Share by Application
Figure 24. Global Hospital-Acquired Infections Assays Market Share by Application (2020-2025)
Figure 25. Global Hospital-Acquired Infections Assays Market Share by Application in 2024
Figure 26. Global Hospital-Acquired Infections Assays Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Hospital-Acquired Infections Assays Market Size Market Share by Region (2020-2025)
Figure 28. North America Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Hospital-Acquired Infections Assays Market Size Market Share by Country in 2024
Figure 30. U.S. Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Hospital-Acquired Infections Assays Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Hospital-Acquired Infections Assays Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Hospital-Acquired Infections Assays Market Share by Country in 2024
Figure 35. Germany Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Hospital-Acquired Infections Assays Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Hospital-Acquired Infections Assays Market Size Market Share by Region in 2024
Figure 42. China Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Hospital-Acquired Infections Assays Market Size and Growth Rate (M USD)
Figure 48. South America Hospital-Acquired Infections Assays Market Size Market Share by Country in 2024
Figure 49. Brazil Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Hospital-Acquired Infections Assays Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Hospital-Acquired Infections Assays Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Hospital-Acquired Infections Assays Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Hospital-Acquired Infections Assays Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Hospital-Acquired Infections Assays Market Share Forecast by Type (2026-2035)
Figure 61. Global Hospital-Acquired Infections Assays Market Share Forecast by Application (2026-2035)
